QA: Mylan INC in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000069499_2015_Mylan_INC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000069499, Mylan INC

  xvar xval
0 AssetsCurrent 6,786,900,000
1 IntangibleAssetsNetIncludingGoodwill 6,396,400,000
2 PropertyPlantAndEquipmentNet 1,785,700,000
3 remainder_Assets 917,600,000
4 LiabilitiesCurrent 5,305,700,000
5 LiabilitiesNoncurrent 7,069,500,000
6 remainder_Liabilities 235,400,000
7 CostOfGoodsAndServicesSold 4,231,464,695
8 SellingGeneralAndAdministrativeExpense 1,659,338,884
9 ResearchAndDevelopmentExpense 604,558,656
10 remainder_Expenses 335,414,070
11 remainder_Revenues 7,852,759,770
12 remainder_NetIncome -55,369,879
13 remainder_ComprehensiveNetIncome -3,720,205,245
  yvar yval
0 Assets 15,886,600,000
1 Liabilities 12,610,600,000
2 Expenses 6,830,776,305
3 Revenues 7,852,759,770
4 StockholdersEquity 3,276,000,000
5 NetIncome 966,613,586
6 ComprehensiveNetIncome -893,489,036
7 BaseVar 23,478,155,600
8 EconomicCapitalRatiobeforeLimitedLiability 0.439
9 EconomicCapitalRatio 1.83

Edgar->Model Mapping

Feature Distribution

Change over Time